null Discovery of mechanics of drug targets for COVID-19
Scientists unravel inner workings of cell receptors involved in inflammatory diseases
Source: McGill Newsroom. A team of international researchers, including Stéphane Laporte, PhD, senior scientist at the Research Institute of the McGill University Health Centre and professor of the Division of Endocrinology and Metabolism, McGill University, has discovered the working mechanism of potential drug targets for various diseases such as cancer, rheumatoid arthritis, and even COVID-19. The findings published in Molecular Cell uncover the inner workings of cell receptors that are involved in cancer progression and inflammatory diseases. Read more.
Sept. 29, 2021